The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Maryam Fouladi

Department of Oncology

St Jude Children's Research Hospital

332 North Lauderdale




Name/email consistency: high



  • Department of Oncology, St Jude Children's Research Hospital, 332 North Lauderdale, Memphis, USA. 1999 - 2008


  1. Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. Fouladi, M., Chintagumpala, M., Ashley, D., Kellie, S., Gururangan, S., Hassall, T., Gronewold, L., Stewart, C.F., Wallace, D., Broniscer, A., Hale, G.A., Kasow, K.A., Merchant, T.E., Morris, B., Krasin, M., Kun, L.E., Boyett, J.M., Gajjar, A. J. Clin. Oncol. (2008) [Pubmed]
  2. Phase I study of everolimus in pediatric patients with refractory solid tumors. Fouladi, M., Laningham, F., Wu, J., O'Shaughnessy, M.A., Molina, K., Broniscer, A., Spunt, S.L., Luckett, I., Stewart, C.F., Houghton, P.J., Gilbertson, R.J., Furman, W.L. J. Clin. Oncol. (2007) [Pubmed]
  3. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Fouladi, M., Nicholson, H.S., Zhou, T., Laningham, F., Helton, K.J., Holmes, E., Cohen, K., Speights, R.A., Wright, J., Pollack, I.F. Cancer (2007) [Pubmed]
  4. Histone deacetylase inhibitors in cancer therapy. Fouladi, M. Cancer Invest. (2006) [Pubmed]
  5. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study. Fouladi, M., Blaney, S.M., Poussaint, T.Y., Freeman, B.B., McLendon, R., Fuller, C., Adesina, A.M., Hancock, M.L., Danks, M.K., Stewart, C., Boyett, J.M., Gajjar, A. Cancer (2006) [Pubmed]
  6. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. Fouladi, M., Gilger, E., Kocak, M., Wallace, D., Buchanan, G., Reeves, C., Robbins, N., Merchant, T., Kun, L.E., Khan, R., Gajjar, A., Mulhern, R. J. Clin. Oncol. (2005) [Pubmed]
  7. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. Fouladi, M., Chintagumpala, M., Laningham, F.H., Ashley, D., Kellie, S.J., Langston, J.W., McCluggage, C.W., Woo, S., Kocak, M., Krull, K., Kun, L.E., Mulhern, R.K., Gajjar, A. J. Clin. Oncol. (2004) [Pubmed]
  8. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945. Fouladi, M., Hunt, D.L., Pollack, I.F., Dueckers, G., Burger, P.C., Becker, L.E., Yates, A.J., Gilles, F.H., Davis, R.L., Boyett, J.M., Finlay, J.L. Cancer (2003) [Pubmed]
  9. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients. Fouladi, M., Helton, K., Dalton, J., Gilger, E., Gajjar, A., Merchant, T., Kun, L., Newsham, I., Burger, P., Fuller, C. Cancer (2003) [Pubmed]
  10. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor. Fouladi, M., Gajjar, A., Boyett, J.M., Walter, A.W., Thompson, S.J., Merchant, T.E., Jenkins, J.J., Langston, J.W., Liu, A., Kun, L.E., Heideman, R.L. J. Clin. Oncol. (1999) [Pubmed]
WikiGenes - Universities